Loading...

InflaRx N.V.

IF0.DEXETRA
Healthcare
Biotechnology
2.94
0.00(0.00%)

InflaRx N.V. (IF0.DE) Stock Overview

Explore InflaRx N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap129.9M
P/E Ratio-3.04
EPS (TTM)$-1.21
ROE-0.66%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.89

IF0.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of InflaRx N.V. (IF0.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.04 and a market capitalization of 129.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;